The registration of Active Pharmaceutical Ingredients (APIs) in Pakistan is regulated by the Drug Regulatory Authority of Pakistan (also known as DRAP). In this article, we will give you an overview of the API registration process in Pakistan, starting with a brief introduction to regulatory framework, application procedures, and the roles of various stakeholders involved in the process. So, without further delay, let’s dive right into the article!
Introduction
Active Pharmaceutical Ingredients (APIs) are the biologically active components in pharmaceutical drugs responsible for producing the intended therapeutic effects. In API registration process, the efficacy, quality, and safety of APIs, along with many other factors, are assessed before market approval. In Pakistan, the registration of APIs is governed by the Drug Regulatory Authority of Pakistan (DRAP).
The API registration process in Pakistan differs from the registration of finished drug products. While both processes are overseen by DRAP, API registration focuses specifically on the active substances used in drug formulations, evaluating their quality, manufacturing processes, and compliance with Good Manufacturing Practices (GMP). In contrast, the drug product registration process undergoes a broader assessment, including the finished product's formulation, therapeutic efficacy, safety profile, and labeling.
Internationally, the approach to API and drug product registration varies from regions to regions based on applicable local regulatory requirements. However, many countries adopt the Common Technical Document (CTD) format, developed by the International Council for Harmonisation (ICH), to standardize the submission of information for the registration of pharmaceuticals. Pakistan too has adapted the CTD format for the registration of human pharmaceutical drug products, as indicated in DRAP's guidance documents.
Regulatory Framework in Pakistan
In Pakistan, the regulation of Active Pharmaceutical Ingredients (APIs) is governed by a comprehensive legal framework established through the Drug Regulatory Authority of Pakistan (DRAP) and some legislative acts.
Drug Regulatory Authority of Pakistan (DRAP)
Established under the Drug Regulatory Authority of Pakistan Act, 2012 (DRAP Act), DRAP serves as the autonomous body responsible for the regulation and enforcement of pharmaceutical standards across the country. DRAP was created to provide effective coordination and enforcement of The Drugs Act, 1976, and to harmonize inter-provincial trade and commerce of therapeutic goods. DRAP's mandate encompasses a wide range of functions, including the registration, licensing, and oversight of pharmaceuticals so that the therapeutic goods available in the market meet prescribed standards of quality, safety, and efficacy. DRAP operates under the administrative control of the Ministry of National Health Services, Regulations & Coordination.
Legal Provisions
The foundational legal instrument for drug regulation in Pakistan is the Drugs Act, 1976. It provides the legal provisions for regulating the import, export, manufacture, storage, distribution, and sale of drugs so that all pharmaceutical products meet defined standards of quality and are safe for consumer use.
Through the establishment of DRAP and the enactment of these legal provisions, Pakistan has developed a regulated approach to pharmaceutical regulation, with the sole purpose of protecting public health.
API Registration Process in Pakistan
The registration of Active Pharmaceutical Ingredients (APIs) in Pakistan is a structured process governed by the Drug Regulatory Authority of Pakistan (DRAP). The application process for API registration encompasses several steps. These are:
1. Preparation of Dossier
In the first step, applicants are required to compile a dossier adhering to the Common Technical Document (CTD) format, as mandated by DRAP. The CTD format standardizes the presentation of data and facilitates the evaluation process. The dossier consists of three main modules:
Module 1: Administrative Information
It includes:
o Details of the applicant and manufacturer, inc...
(All Rights Reserved)